GOLDMAN SACHS GROUP INC - SALIX PHARMACEUTICALS INC ownership

SALIX PHARMACEUTICALS INC's ticker is and the CUSIP is 795435AC0. A total of 20 filers reported holding SALIX PHARMACEUTICALS INC in Q1 2015. The put-call ratio across all filers is - and the average weighting 0.6%.

Quarter-by-quarter ownership
GOLDMAN SACHS GROUP INC ownership history of SALIX PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2015$45,000
+50.0%
12,0000.0%0.00%
Q4 2014$30,000
-25.0%
12,0000.0%0.00%
Q3 2014$40,000
-99.7%
12,000
-99.8%
0.00%
-100.0%
Q1 2014$13,167,000
-38.4%
5,873,000
-46.0%
0.00%
-42.9%
Q4 2013$21,381,000
+24196.6%
10,867,000
+16618.5%
0.01%
Q2 2012$88,000
+125.6%
65,000
+124.1%
0.00%
Q1 2012$39,00029,0000.00%
Other shareholders

There were no reported owners of SALIX PHARMACEUTICALS INC in Q1 2015.

NameSharesValueWeighting ↓
View complete list of SALIX PHARMACEUTICALS INC shareholders